4//SEC Filing
Zung Jonathan B. 4
Accession 0001694665-22-000019
CIK 0001694665other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:56 PM ET
Size
5.4 KB
Accession
0001694665-22-000019
Insider Transaction Report
Form 4
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-19+115,000→ 115,000 totalExercise: $5.05Exp: 2032-01-19→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001837972
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:56 PM ET
- Size
- 5.4 KB